Skip to main content

Table 1 Clinical and metabolic characteristics of the subjects as a function of the diagnosis of MS based on the NCEP-ATPIII criteria

From: Metabolic Syndrome as a Cardiovascular Disease Risk Factor: Patients Evaluated in Primary Care

  TOTAL (n = 720) Metabolic Syndrome (NCEP) P
   No (n = 510) Yes (n = 210)  
Females 60.6(436) 51.4(262) 82.8(174) < 0.001
Age;years 66.9(SD = 10.9) 63.2(SD = 11.2) 70.6(SD = 9.3) < 0.001
Obesity 39.6(285) 22.3(114) 81.4(171) < 0.001
BMI(kg/m2) 29.1(SD = 5.2) 27.7(SD = 4.6) 32.1(SD = 5.2) < 0.001
   FEMALES 27.9(SD = 6.0) 27.5(SD = 5.4) 33.5(SD = 4.9) < 0.001
   MALES 27.7(SD = 4.7) 27.1(SD = 3.9) 28.7(SD = 5.3) < 0.001
Abdominal circumference(cm) 100.7(SD = 11.7) 95.8(SD = 13.0) 107.2(SD = 13.8) < 0.03
Blood pressure 48.9(352) 36.1(184) 80.0(168) < 0.001
BPS(mmHg) 132.0(SD = 17.6) 130.3(SD = 19.4) 142.0(SD = 18.7) < 0.001
   FEMALES 131.6(SD = 20.7) 127.4(SD = 19.3) 140.4(SD = 17.8) < 0.001
   MALES 133.4(SD = 18.1) 129.1(SD = 16.3) 145.6(SD = 18.7) < 0.001
BPD(mmHg) 78.1(SD = 11.6) 78.4(SD = 11.7) 82.4(SD = 11.1) < 0.001
   FEMALES 78.5(SD = 11.7) 76.4(SD = 11.1) 81.6(SD = 10.5) < 0.001
   MALES 79.6(SD = 11.6) 79.0(SD = 11.0) 83.7(SD = 11.6) < 0.001
Diabetes mellitus 19.7(142) 8.8(45) 60.5(127) < 0.001
Baseline glycemia(mg/dL) 106.7(SD = 38.7) 102.1(SD = 31.7) 127.4(SD = 55.8) < 0.001
   FEMALES 111.4(SD = 42.3) 97.3 (SD = 27.5) 139.4(SD = 51.8) < 0.001
   MALES 114.8(SD = 46.0) 103.6(SD = 41.0) 133.5(SD = 48.1) < 0.001
HbA1c;% 5.6(SD = 1.5) 5.4(SD = 1.3) 6.2(SD = 2.0) < 0.001
   FEMALES 6.04 (SD = 1.8) 5.32(SD = 1.2) 6.7(SD = 2.0) < 0.001
   MALES 6.11(SD = 1.9) 6.03(SD = 2.1) 6.2(SD = 1.6) < 0.001
Dyslipemia 29.0(209) 16.1(82) 60.5(127) < 0.001
Total cholesterol(mg/dL) 219.2(SD = 40.1) 217.3(SD = 42.5) 226.6(SD = 46.3) < 0.01
   FEMALES 219.6(SD = 41.5) 215.4(SD = 44.2) 239.7(SD = 52.6) < 0.001
   MALES 218.5(SD = 43.9) 217.9(SD = 43.9) 223.5(SD = 42.8) < 0.01
LDL-cholesterol(mg/dL) 141.3(SD = 36.3) 140.9(SD = 35.9) 143.2(SD = 36.7) NS
   FEMALES 141.2(SD = 36.1) 139.8(SD = 36.3) 141.7(SD = 36.5) NS
   MALES 145.2(SD = 37.2) 143.3(SD = 35.8) 147.2(SD = 39.4) NS
HDL-cholesterol(mg/dL) 54.4(SD = 19.0) 54.0(SD = 16.6) 50.8(SD = 17.4) < 0.001
   FEMALES 53.2(SD = 18.2) 58.7(SD = 18.4) 52.4(SD = 16.1) < 0.001
   MALES 50.9(SD = 22.3) 52.2(SD = 20.6) 50.1(SD = 20.8) NS
Triglycerides(mg/dL) 151.4(SD = 109.6) 147.0(SD = 107.0) 165.4(SD = 118.3) < 0.001
   FEMALES 134.0(SD = 79.2) 104.4(SD = 59.2) 177.5(SD = 87.1) < 0.001
   MALES 174.0(SD = 135.7) 148.0 (SD = 123) 210.5(SD = 146.2) < 0.002
Microalbuminuria(mg/d) 38.3(SD = 131.2) 18.2(SD = 64.1) 103.8(SD = 233) < 0.002
   FEMALES 17.8(SD = 42.3) 13.7(SD = 18.2) 24.5(SD = 64.1) < 0.001
   MALES 65.5(SD = 191.3) 42.5(SD = 112.4) 101.7(SD = 269) < 0.001
CVD risk(% at 10 years) 13.8(SD = 10.0) 13.4(SD = 8.3) 23.8(SD = 10.0) < 0.001
   FEMALES 8.7(SD = 7.9) 6.5(SD = 5.3) 17.3(SD = 10.0) < 0.001
   MALES 19.7(SD = 11.1) 14.4(SD = 9.8) 26.4(SD = 11.6) < 0,001
REGICOR(% at 10 years) 8.8(SD = 9.8) 7.2(SD = 8.9) 10.7(SD = 9.5) < 0.001
   FEMALES 3.7(SD = 5.3) 2.9(SD= 4.7) 5.6(SD = 7.1) < 0.001
   MALES 10.1(SD = 8.8) 8.2(SD = 9.0) 13.5(SD = 9.4) < 0.001
CVD complications 19.7(142) 113 individuals 11.0(56) 55 individuals 40.9(86) 58 individuals < 0.001
Cerebrovascular 3.3(24) 2.3(12) 5.7(12) < 0.001
Coronary 4.2(30) 2.9(15) 7.1(15) < 0.001
Peripheral vascular 4.9(35) 3.3(17) 8.6(18) < 0.001
Retinopathy 2.5(18) 1.4(7) 5.2(11) < 0.02
Nephropathy 4.0(29) 0.8(4) 11.9(25) < 0.001
Neuropathy 0.8(6) 0.2(1) 2.4(5) < 0.001
  1. The data are expressed in percentages (absolute values) and mean (SD:standard deviation). BPS = systolic blood pressure; BPD = diastolic blood pressure; BMI = body mass index; CVD = cardiovascular disease risk according to the Framingham predictive equation; REGICOR: cardiovascular disease risk tables based on the Framingham equations and calibrated for Spain; NS = not significant